On Thursday, Shares of Chesapeake Energy Corporation (NYSE:CHK), lost -1.74% to $11.88, hitting its lowest level, despite oil prices made small gains Thursday on the back of a weaker dollar and data that suggests a decrease in crude at a key U.S. storage hub.
Light, sweet crude for July delivery, the U.S. benchmark, gained 53 cents, or 0.9%, to $60.45 a barrel on the New York Mercantile Exchange. The global Brent contract for August ended up 39 cents, or 0.6%, at $64.26 a barrel on the ICE Futures Europe exchange, according to WSJ.com.
Chesapeake Energy Corporation engages in the acquisition, exploration, and development of properties for the production of oil, natural gas and natural gas liquids (NGL) from underground reservoirs in the United States.
Shares of Organovo Holdings, Inc. (NYSEMKT:ONVO), declined -15.77% to $4.38, during its last trading session.
Organovo Holdings, declared the sale of 9,425,000 shares of its common stock in an underwritten public offering at a price to the public of $4.25 per share. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 1,413,750 shares of common stock on the same terms and conditions. The gross offering proceeds to Organovo from the sale of the shares are predictable to be $40,056,250, before deducting underwriting discounts and commissions and other estimated offering expenses and not taking into account any proceeds from the exercise of the underwriters’ option. The offering is predictable to close on or about June 23, 2015, subject to customary closing conditions.
The Company anticipates using the net proceeds from this offering for general corporate purposes, counting research and development, the development and commercialization of its products, general administrative expenses, license or technology acquisitions, and working capital and capital expenditures.
Jefferies LLC and Piper Jaffray & Co. are acting as joint book-running managers for the offering. Cantor Fitzgerald & Co. is acting as a co-manager for the offering.
Organovo Holdings, Inc., an early commercial stage company, focuses on developing and commercializing functional human tissues that could be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs.
Finally, SouFun Holdings Ltd. (NYSE:SFUN), ended its last trade with -3.69% loss, and closed at $9.39, despite technology stocks remained higher Thursday’s afternoon trade with shares of technology companies in the S&P 500 advancing more than 0.7%.
SouFun Holdings Limited, declared that it will hold its 2015 annual general meeting of shareholders at Building 5, Zone 4, Hanwei International Plaza, No. 186 South 4th Ring Road, Fengtai District, Beijing 100160, the People’s Republic of China on July 3, 2015 at 10:30 a.m. (local time). The only proposal to be presented for shareholders’ approval at the annual general meeting is the approval of the Company’s 2015 Stock Incentive Plan. The Company’s board of directors has fixed June 4, 2015 as the record date (the “Record Date”) for determining the shareholders entitled to receive notice of the annual general meeting or any adjournment or postponement thereof. Holders of record of the Company’s ordinary shares at the close of business on the Record Date are entitled to attend the annual general meeting and any adjournment or postponement thereof in person.
SouFun Holdings Limited operates a real estate Internet portal, and home furnishing and improvement Websites in the People’s Republic of China. The company offers marketing services on its Websites, primarily through advertisements to real estate developers in the marketing phase of new property developments, in addition to to real estate agencies; and suppliers of home furnishing and improvement, and other home-related products and services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
